Cerebrospinal-fluid cytokine and chemokine profile in patients with pneumococcal and meningococcal meningitis

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Coutinho, Leonam G ^a   Grandgirard, Denis ^b   Leib, Stephen L ^b   Agnez Lima, Lucymara F ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cerebrospinal fluid; Chemokines; Cytokines; Interferon gamma; Meningococcal meningitis; Pneumococcal meningitis

Indexed keywords

CHEMOKINE; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EPIDEMIC MENINGITIS; HUMAN; INFANT; LUMBAR PUNCTURE; NEISSERIA MENINGITIDIS; NONHUMAN; PNEUMOCOCCAL MENINGITIS; PROTEIN EXPRESSION; STREPTOCOCCUS PNEUMONIAE; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYTOKINES; HUMANS; MENINGITIS, MENINGOCOCCAL; MENINGITIS, PNEUMOCOCCAL; MIDDLE AGED; YOUNG ADULT;

EID: 84880184662     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-326     Document Type: Article

References (46)

1. Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, Lefkowitz L, Perkins BA. Bacterial meningitis in the United States in 1995. N Engl J Med 1997, 337:970-9762.
2. Silva WA, Pinheiro AM, Coutinho LG, Marinho LA, Lima LF. Epidemiological profile of acute bacterial meningitis in the state of Rio Grande do Norte, Brazil. Rev Soc Bras Med Trop 2010, 43:455-457.
3. Novaes HM, Sartori AM, Soárez PC. Hospitalization rates for pneumococcal disease in Brazil, 2004-2006. Rev Saude Publica 2011, 45:539-547.
4. Sáfadi MA, Cintra OA. Epidemiology of meningococcal disease in Latin America, current situation and opportunities for prevention. Neurol Res 2010, 32:263-271.
5. Tauber MG, Moser B. Cytokines and chemokines in meningeal inflammation, biology and clinical implications. Clin Infect Dis 1999, 28:1-11.
6. van Furth AM, Roord JJ, van Furth R. Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. InfectImmun 1996, 64:4883-4890.
7. Brandt CT, Caye-Thomasen P, Lund SP, Worsoe L, Ostergaard C, Frimodt-Moller N, Espersen F, Thomsen J, Lundgren JD. Hearing loss and cochlear damage in experimental pneumococcal meningitis, with special reference to the role of neutrophil granulocytes. Neurobiol Dis 2006, 23:300-311.
8. Haberl RL, Anneser F, Kodel U, Pfister HW. Is nitric oxide involved as a mediator of cerebrovascular changes in the early phase of experimental pneumococcal meningitis?. NeurolRes 1994, 16:108-112.
9. Leppert D, Leib SL, Grygar C, Miller KM, Schaad UB, Hollander GA. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis, association with blood-brain barrier damage and neurological sequelae. ClinInfect Dis 2000, 31:80-84.
10. Zwijnenburg PJ, de Bie HM, Roord JJ, van der Poll T, van Furth AM. Chemotactic activity of CXCL5 in cerebrospinal fluid of children with bacterial meningitis. J Neuroimmunol 2003, 145:148-153.
11. Azuma H, Tsuda N, Sasaki K, Okuno A. Clinical significance of cytokine measurement for detection of meningitis. J Pediatr 1997, 131:463-465.
12. Klein M, Obermaier B, Angele B, Pfister HW, Wagner H, Koedel U, Kirschning CJ. Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4. J Infect Dis 2008, 198:1028-1036.
13. Mogensen TH, Paludan SR, Kilian M, Ostergaard L. Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns. J Leukocyte Biol 2006, 80:267-277.
14. Ribes S, Ebert S, Regen T, Agarwal A, Tauber SC, Czesnik D, Spreer A, Bunkowski S, Eiffert H, Hanisch UK, Hammerschmidt S, Nau R. Toll-like receptor stimulation enhances phagocytosis and intracellular killing of nonencapsulated and encapsulated Streptococcus pneumoniae by murine microglia. Infect Immun 2010, 78:865-871.
15. Sjolinder H, Mogensen TH, Kilian M, Jonsson AB, Paludan SR. Important role for Toll-like receptor 9 in host defense against meningococcal sepsis. InfectImmun 2008, 76:5421-5428.
16. Kastenbauer S, Koedel U, Becker BF, Pfister HW. Oxidative stress in bacterial meningitis in humans. Neurology 2002, 58:186-191.
17. Mastroianni CM, Lancella L, Mengoni F, Lichtner M, Santopadre P, D'Agostino C, Ticca F, Vullo V. Chemokine profiles in the cerebrospinal fluid (CSF) during the course of pyogenic and tuberculous meningitis. Clin Exp Immunol 1998, 114:210-214.
18. de Jonge RC, van Furth AM, Wassenaar M, Gemke RJ, Terwee CB. Predicting sequelae and death after bacterial meningitis in childhood, a systematic review of prognostic studies. BMC Infect Dis 2010, 10:232.
19. Worsøe L, Cayé-Thomasen P, Brandt CT, Thomsen J, Østergaard C. Factors associated with the occurrence of hearing loss after pneumococcal meningitis. Clin Infect Dis 2010, 51:917-924.
20. Borchorst S, Møller K. The role of dexamethasone in the treatment of bacterial meningitis - a systematic review. Acta Anaesthesiol Scand 2012, 56:1210-1221.
21. Dulkerian SJ, Kilpatrick L, Costarino AT, McCawley L, Fein J, Corcoran L, Zirin S, Harris MC. Cytokine elevations in infants with bacterial and aseptic meningitis. J Pediatr 1995, 126:872-876.
22. Glimaker M, Kragsbjerg P, Forsgren M, Olcen P. Tumor necrosis factor-alpha (TNF alpha) in cerebrospinal fluid from patients with meningitis of different etiologies, high levels of TNF alpha indicate bacterial meningitis. J Infect Dis 1993, 167:882-889.
23. Kornelisse RF, Hack CE, Savelkoul HF, van der Pouw Kraan TC, Hop WC, van Mierlo G, Suur MH, Neijens HJ, de Groot R. Intrathecal production of interleukin-12 and gamma interferon in patients with bacterial meningitis. Infect Immun 1997, 65:877-881.
24. Mukai AO, Krebs VL, Bertoli CJ, Okay TS. TNF-alpha and IL-6 in the diagnosis of bacterial and aseptic meningitis in children. Pediatr Neurol 2006, 34:25-29.
25. Ohga S, Aoki T, Okada K, Akeda H, Fujioka K, Ohshima A, Mori T, Minamishima I, Ueda K. Cerebrospinal fluid concentrations of interleukin-1 beta, tumour necrosis factor-alpha, and interferon gamma in bacterial meningitis. Arch Dis Child 1994, 70:123-125.
26. Sharief MK, Ciardi M, Thompson EJ. Blood-brain barrier damage in patients with bacterial meningitis, association with tumor necrosis factor-alpha but not interleukin-1 beta. J Infect Dis 1992, 166:350-358.
27. Akalin H, Akdis AC, Mistik R, Helvaci S, Kilicturgay K. Cerebrospinal fluid interleukin-1 beta/interleukin-1 receptor antagonist balance and tumor necrosis factor-alpha concentrations in tuberculous, viral and acute bacterial meningitis. Scand J Infect Dis 1994, 26:667-674.
28. Friedland JS, Shattock R, Remick DG, Griffin GE. Mycobacterial 65-kD heat shock protein induces release of proinflammatory cytokines from human monocytic cells. Clin Exp Immunol 1993, 91:58-62.
29. van Deuren M, Netea MG, Hijmans A, Demacker PN, Neeleman C, Sauerwein RW, Bartelink AK, van der Meer JW. Posttranscriptional down-regulation of tumour necrosis factor-alpha and interleukin-1beta production in acute meningococcal infections. J Infect Dis 1998, 177:1401-1405.
30. Marzouk O. Clinical and laboratory aspects of meningococcal disease in childhood 1994, MD Thesis: Liverpool University.
31. van Deuren M, van der Ven-Jongekrijg J, Demacker PN, Bartelink AK, van Dalen R, Sauerwein RW, Gallati H, Vannice JL, van der Meer JW. Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect Dis 1994, 169:157-161.
32. Baines PB, Hart CA. Severe meningococcal disease in childhood. Br J Anaesth 2003, 90:72-83.
33. Davenport V, Groves E, Hobbs CG, Williams NA, Heyderman RS. Regulation of Th-1 T cell-dominated immunity to Neisseria meningitidis within the human mucosa. Cell Microbiol 2007, 9:1050-1061.
34. Holub M, Scheinostova M, Dzupova O, Fiserova A, Beran O, Kalmusova J, Musilek M, Krizova P. Neisseria meningitidis strains from patients with invasive meningococcal disease differ in stimulation of cytokine production. Folia Microbiol 2007, 52:525-528.
35. Hessle C, Andersson B, WoldA E. Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production. Infect Immun 2000, 68:3581-3586.
36. Borish LC, Steinke JW. 2. Cytokines and chemokines. J Allerg ClinImmun 2003, 111:S460-S475.
37. D'Elios MM, Benagiano M, Della Bella C, Amedei A. T-cell response to bacterial agents. J Infect Dev C tries 2011, 5:640-645.
38. Olliver M, Hiew J, Mellroth P, Henriques-Normark B, Bergman P. Human monocytes promote Th1 and Th17 responses to Streptococcus pneumoniae. Infect Immun 2011, 79:4210-4217.
39. Fortnum HM. Hearing impairment after bacterial meningitis, a review. Arch Dis Child 1992, 67:1128-1133.
40. Hausler KG, Prinz M, Nolte C, Weber JR, Schumann RR, Kettenmann H, Hanisch UK. Interferon-gamma differentially modulates the release of cytokines and chemokines in lipopolysaccharide- and pneumococcal cell wall-stimulated mouse microglia and macrophages. Eur J Neurosc 2002, 16:2113-2122.
41. Deshmukh SD, Kremer B, Freudenberg M, Bauer S, Golenbock DT, Henneke P. Macrophages recognize streptococci through bacterial single-stranded RNA. EMBO Rep 2010, 12:71-76.
42. Carrol ED, Guiver M, Nkhoma S, Mankhambo LA, Marsh J, Balmer P, Banda DL, Jeffers G, White SA, Molyneux EM, Molyneux ME, Smyth RL, Hart CA. High pneumococcal DNA loads are associated with mortality in Malawian children with invasive pneumococcal disease. Pediatr Infect Dis J 2007, 26:416-422.
43. Dumont RA, Car BD, Voitenok NN, Junker U, Moser B, Zak O, O'Reilly T. Systemic neutralization of interleukin-8 markedly reduces neutrophilic pleocytosis during experimental lipopolysaccharide-induced meningitis in rabbits. Infect Immun 2000, 68:5756-5763.
44. Ostergaard C, Yieng-Kow RV, Larsen CG, Mukaida N, Matsushima K, Benfield T, Frimodt-Moller N, Espersen F, Kharazmi A, Lundgren JD. Treatment with a monocolonal antibody to IL-8 attenuates the pleocytosis in experimental pneumococcal meningitis in rabbits when given intravenously, but not intracisternally. Clin Exp Immunol 2000, 122:207-211.
45. Diab A, Abdalla H, Li HL, Shi FD, Zhu J, Hojberg B, Lindquist L, Wretlind B, Bakhiet M, Link H. Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1alpha attenuates neutrophil recruitment in the central nervous system during experimental bacterial meningitis. Infect Immun 1999, 67:2590-2601.
46. van de Beek D, Farrar JJ, de Gans J, Mai NT, Molyneux EM, Peltola H, Peto TE, Roine I, Scarborough M, Schultsz C, Thwaites GE, Tuan PQ, Zwinderman AH. Adjunctive dexamethasone in bacterial meningitis, a meta-analysis of individual patient data. Lancet Neurol 2010, 9:254-263.